A novel inhibitor of fatty acid synthase shows activity against HER2+ breast cancer xenografts and is active in anti-HER2 drug-resistant cell lines

  1. Puig, T.
  2. Aguilar, H.
  3. Cufí, S.
  4. Oliveras, G.
  5. Turrado, C.
  6. Ortega-Gutiérrez, S.
  7. Benhamú, B.
  8. López-Rodríguez, M.L.
  9. Urruticoechea, A.
  10. Colomer, R.
Zeitschrift:
Breast Cancer Research

ISSN: 1465-5411 1465-542X

Datum der Publikation: 2011

Ausgabe: 13

Nummer: 6

Art: Artikel

DOI: 10.1186/BCR3077 GOOGLE SCHOLAR lock_openOpen Access editor

Ziele für nachhaltige Entwicklung